Status:
UNKNOWN
Role of Retina in Mechanisms of Illusions and Visual Hallucinations Observed in Idiopathic Parkinson's Disease
Lead Sponsor:
University Hospital, Clermont-Ferrand
Collaborating Sponsors:
Fondation de France
Conditions:
Parkinson's Disease
Visual Hallucinations
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Parkinson's disease is characterized not only by motor symptoms but also by psycho-behavioral symptoms including Visual Hallucinations (VH) and illusions (I), that are generally associated with a seve...
Detailed Description
Parkinson's disease is a neurodegenerative disorder characterized by tremor, rigidity and akinesia, but patients can also present various non-motor symptoms in the course of their illness, including v...
Eligibility Criteria
Inclusion
- \- patients presenting with a Parkinson's Disease according to UKPDSBB criteria
- Patients affiliated to a health insurance company.
- HV-/IV+ Group : patients presenting illusions criteria according to SCOPA, with no visual hallucinations
- HV+/IV- Group : patients presenting visual hallucinations (SCOPA) without illusions
- HV-/IV- Group : patients without hallucinations or illusions SCOPA)
Exclusion
- Patients with other neurological diseases than PD.
- Patients with active psychiatric pathologies (psychosis).
- Patients unable to remain sit and still during different ophtalmological exams due to camptocormia and dyskinesias.
Key Trial Info
Start Date :
March 8 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 30 2020
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03454269
Start Date
March 8 2018
End Date
March 30 2020
Last Update
March 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Clermont-Ferrand
Clermont-Ferrand, France, 63003